Droxidopa
- Generic Name
- Droxidopa
- Brand Names
- Northera
- Drug Type
- Small Molecule
- Chemical Formula
- C9H11NO5
- CAS Number
- 23651-95-8
- Unique Ingredient Identifier
- J7A92W69L7
- Background
Droxidopa is a precursor of noradrenaline that is used in the treatment of Parkinsonism. It is approved for use in Japan and is currently in trials in the U.S. The racaemic form (dl-threo-3,4-dihydroxyphenylserine) has also been used, and has been investigated in the treatment of orthostatic hypotension. There is a deficit of noradrenaline as well as of dopa...
- Indication
For treatment of neurogenic orthostatic hypotension (NOH) associated with various disorders including Multiple System Atrophy, Familial Amyloid Polyneuropathy, hemodialysis induced hypotension and Parkinson's Disease. Also investigated for use/treatment in neurologic disorders, nephropathy, blood (blood forming organ disorders, unspecified), and dizzy/fainti...
- Associated Conditions
- Symptomatic Neurogenic Orthostatic Hypotension (NOH)
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.